A microdissection approach to detect molecular markers during progression of prostate cancer.

por Berthon, P., Dimitrov, T., Stower, M., Cussenot, O., Maitland, N. J.
Publicado 1995

Clinical relevance of genetic instability in prostatic cells obtained by prostatic massage in early prostate cancer

por Thuret, R, Chantrel-Groussard, K, Azzouzi, A-R, Villette, J-M, Guimard, S, Teillac, P, Berthon, P, Houlgatte, A, Latil, A, Cussenot, O
Publicado 2005

S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors

por Rehman, I, Cross, S S, Azzouzi, A-R, Catto, J W F, Deloulme, J C, Larre, S, Champigneuille, J, Fromont, G, Cussenot, O, Hamdy, F C
Publicado 2004

Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram

por Yates, D R, Hupertan, V, Colin, P, Ouzzane, A, Descazeaud, A, Long, J A, Pignot, G, Crouzet, S, Rozet, F, Neuzillet, Y, Soulie, M, Bodin, T, Valeri, A, Cussenot, O, Rouprêt, M
Publicado 2012

Impact de la pandémie de COVID-19 sur l’activité chirurgicale au sein des services d’urologie de l’Assistance Publique – Hôpitaux de Paris

por Pinar, U., Anract, J., Duquesne, I., Dariane, C., Chartier-Kastler, E., Cussenot, O., Desgrandchamps, F., Hermieu, J.-F., Irani, J., de La Taille, A., Méjean, A., Mongiat-Artus, P., Peyromaure, M., Barrou, B., Zerbib, M., Rouprêt, M.
Publicado 2020